{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:02:51Z","timestamp":1783191771505,"version":"3.54.6"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"DOI":"10.7759\/cureus.87724","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:38:13Z","timestamp":1752237493000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Severe Immune Thrombocytopenia Following Dupilumab Use for Eustachian Tube Dysfunction: A Case Report"],"prefix":"10.7759","author":[{"given":"Amanda J","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George JN","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998, 129:886-90. 10.7326\/0003-4819-129-11_part_1-199812010-00009","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster RH","year":"2007","unstructured":"Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007, 357:580-7. 10.1056\/NEJMra066469","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2013.05.005","article-title":"Approach to the diagnosis and management of drug-induced immune thrombocytopenia","volume":"27","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013, 27:137-45. 10.1016\/j.tmrv.2013.05.005","journal-title":"Transfus Med Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi NA","year":"2016","unstructured":"Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016, 15:35-50. 10.1038\/nrd4624","journal-title":"Nat Rev Drug Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert C","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al.. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019, 394:1638-50. 10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3734","article-title":"Immune thrombocytopenic purpura in a patient with atopic dermatitis treated with dupilumab","volume":"101","author":"Frey S","year":"2021","unstructured":"Frey S, Kendziora B, Holch JW, Lindner L, French LE, Wollenberg A. Immune thrombocytopenic purpura in a patient with atopic dermatitis treated with dupilumab. Acta Derm Venereol. 2021, 101:adv00409.","journal-title":"Acta Derm Venereol"},{"key":"ref9","article-title":"An uncharacteristic presentation of Evans syndrome following treatment with dupilumab","volume":"13","author":"Rutherford AI","year":"2021","unstructured":"Rutherford AI, Entezami P, Wetter DA, King KS, Bridges AG. An uncharacteristic presentation of Evans syndrome following treatment with dupilumab. Cureus. 2021, 13:e16658.","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-804096","article-title":"How I treat disseminated intravascular coagulation","volume":"131","author":"Levi M","year":"2018","unstructured":"Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018, 131:845-54. 10.1182\/blood-2017-10-804096","journal-title":"Blood"},{"key":"ref11","article-title":"Analysis and mining of dupilumab adverse events based on FAERS database","volume":"15","author":"Gao H","year":"2025","unstructured":"Gao H, Cao L, Liu C. Analysis and mining of dupilumab adverse events based on FAERS database. Sci Rep. 2025, 15:8597.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson EL","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E, et al.. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016, 375:2335-48. 10.1056\/NEJMoa1610020","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda T","year":"2014","unstructured":"Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis. 2014, 58:113-6. 10.1093\/cid\/cit641","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.138","article-title":"Heterogeneity and plasticity of T helper cells","volume":"20","author":"Zhu J","year":"2010","unstructured":"Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res. 2010, 20:34-50. 10.1038\/cr.2009.138","journal-title":"Cell Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner H","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015, 373:1136-52. 10.1056\/NEJMra1406184","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369982-acute-severe-immune-thrombocytopenia-following-dupilumab-use-for-eustachian-tube-dysfunction-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:38:15Z","timestamp":1752237495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369982-acute-severe-immune-thrombocytopenia-following-dupilumab-use-for-eustachian-tube-dysfunction-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.87724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}